Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
BMC software (BMC - Analyst Report) has announced the acquisition of application release automation provider VaraLogix for an undisclosed amount. This acquisition is expected to help BMC expand its DevOps portfolio, which is a tool for IT professionals.
The resultant enhancement to the DevOps portfolio is expected to increase the efficiency, accuracy and speed of application development, which in turn would help IT professionals improve the ROI for their companies. These advantages should help the adoption of the technology and therefore convert to higher revenue for BMC.
The increasing volumes of software applications and their updates are leading to new capabilities that could help companies stay ahead in the race. However, companies generally treat the installation of new applications cautiously, since any mistakes could prove to be costly.
The acquisition is useful in this regard, as the collaboration of the technologies of BMC and VaraLogix creates an abstraction layer that enables IT teams to deploy applications even without prior programming experience. It therefore also addresses the need for advanced application specialists in the installation process.
Although competition is gradually intensifying in the SaaS space, BMC’s focus on its Service segment has enabled it to regain some market share. This apart, the BMC RemedyForce is gaining momentum and is expected to generate additional revenue. Again this acquisition is expected to affect the service business in a positive way.
Moreover, the company is slowly expanding its customer base both on account of market expansion and at the expense of competitors. On the other hand, rationalization of expenditure by different government and private customers may weigh on the overall business volumes of the company. The current economic turmoil may also affect the business going forward.
The company witnessed growth in most of its business segments and generated decent cash flow in the first quarter of 2013. However, we are a bit apprehensive about the bleak business conditions in Europe. Moreover, growing competition from big players such as IBM Inc. (IBM - Analyst Report), Hewlett-Packard Company (HPQ - Analyst Report), EMC Corp. (EMC - Analyst Report) and CA Inc. (CA - Analyst Report) is a challenge for the company.
The company carries a Zacks #3 Rank, implying a short-term Hold rating.
Get the full Analyst Report on BMC - FREE
Get the full Analyst Report on HPQ - FREE
Get the full Analyst Report on CA - FREE
Get the full Analyst Report on IBM - FREE
Get the full Analyst Report on EMC - FREE